The ONE Forum 2021
Published by:
The National Marrow Donor Program
Description
The ONE Forum brings together the global cell therapy community, bringing visibility to the latest innovations in cellular therapies and providing a forum for health care professionals to discuss practical strategies and best practices in delivering treatments for patients with blood cancers and diseases. Learn from and connect with experts and peers in the industry to break down barriers to care. App users can access session content, chat functions, discussion forums, and receive important event information.
Hide
Show More...
Screenshots
The ONE Forum 2021 FAQ
-
Is The ONE Forum 2021 free?
Yes, The ONE Forum 2021 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is The ONE Forum 2021 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does The ONE Forum 2021 cost?
The ONE Forum 2021 is free.
-
What is The ONE Forum 2021 revenue?
To get estimated revenue of The ONE Forum 2021 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Kazakhstan yet.
Ratings History
The ONE Forum 2021 Reviews
No Reviews in Kazakhstan
App doesn't have any reviews in Kazakhstan yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
The ONE Forum 2021 Installs
Last 30 days
The ONE Forum 2021 Revenue
Last 30 daysThe ONE Forum 2021 Revenue and Downloads
Gain valuable insights into The ONE Forum 2021 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Productivity
- Publisher
- The National Marrow Donor Program
- Languages
- English
- Recent release
- 2.15.3 (3 years ago )
- Released on
- Oct 10, 2021 (3 years ago )
- Also available in
- Philippines , India , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Netherlands , Norway , Peru , Israel , Pakistan , Poland , Romania , Russia , Sweden , Singapore , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Denmark , Argentina , Austria , Australia , Azerbaijan , Brazil , Belarus , Canada , Switzerland , Chile , China , Colombia , Germany , United Arab Emirates , Dominican Republic , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Indonesia , Ireland
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.